Slovakia: Difference between revisions

From Beacon
No edit summary
Line 37: Line 37:


=== [[hasReport::Report:_EU_Country_Cancer_Profile_2023_(Slovakia)|Report: EU Country Cancer Profile 2023]] ===
=== [[hasReport::Report:_EU_Country_Cancer_Profile_2023_(Slovakia)|Report: EU Country Cancer Profile 2023]] ===
'''Sponsor, manager or home institution:''' OECD and European Commission.
'''Primary purpose:''' To provide reliable data on cancer prevention and care, identifying trends, disparities, and inequalities among EU Member States and regions to guide interventions under Europe's Beating Cancer Plan.
'''Type of information:''' National cancer burden; Cancer incidence and mortality; Risk factors for cancer; Early detection programs (screenings); Cancer care performance, The impact of COVID-19 on cancer care.
'''Data level''': National level.
'''Access to information:''' Access Information [https://www.oecd-ilibrary.org/social-issues-migration-health/onkologicky-profil-krajiny-slovenska-republika-2023_a70dc924-sk].
</div>
</div>



Revision as of 18:35, 23 May 2024

Go back to Cancer Centers list.

Healthcare System

Registries

Electronic Health Records

Latest Policymaking Initiatives

Reports: National Oncology Institute

Sponsor, manager or home institution: Národný Onkologický Inštitútu.

Primary purpose: To function as a clinical-research, academic, and educational platform to support the National Oncology Program in various areas, including epidemiology, science, research, prevention, screening, diagnosis, treatment, and supportive care.

Type of information: The most common cancers; Cancer diseases; Overview of the availability of palliative care in the health system; Number of capacities in palliative care; Availability of original oncology treatment; Cost-effectiveness of colorectal cancer screening; Participation in opportunistic colorectal cancer screening; Number of breast, cervical, colorectal and lung screenings; Rate of participation in screenings; estimated rate of coverage; Share of clinical stages of malignant tumors; Number and percentage of clinical stages of malignant tumors; List of verified screening mammography workplaces; Number of women invited to a screening mammography examination; Relative rate of women's participation in mammography screening; Number of diagnosed malignancies during mammography screening.

Data level: National and regional level.

Access to information: Access annual reports [1]. Screenings information [2]; Epidemiological report of cancer diseases [3].

Report: EU Country Cancer Profile 2023

Cancer-related Patient Associations and Resources

Compilation: ESMO Patient Guides

Sponsor, manager or home institution: European Society for Medical Oncology

Primary purpose: To translate complex medical language into understandable information for patients.

Available guides: Tumor Pain; Adverse Effects of Immunotherapy; Life after an Oncological Diagnosis;AML; CML; Follicular Lymphoma; Gliomas; Head and Neck Cancer; Liver Cancer; Endometrial Carcinoma; Cervical Carcinoma; Colorectal Cancer; Bone Sarcomas; Non-Small Cell Lung Carcinoma; Pancreatic Cancer; Prostate Cancer; Breast Cancer; Testicular Cancer; Ovarian Cancer; Multiple Myeloma.

Type of information: Information on each guide varies for each cancer type. Generally, guides provide definitions, explanations of causes, diagnosis, treatment, treatment options, care after treatment, among others.

Access to information: List of guides [4].

Quality of Life and Palliative Care Research

List of Articles: Quality of Life [5] and Palliative Care [6].